The fund, run by Daniel S. Loeb, has called on the Swiss food giant to sell its stake in L’Oréal and move more quickly to adapt to changing consumer tastes.
NYS Entity Status
NYS Filing Date
JULY 09, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2013 - J. L. ALLEN CO. NEW YORK LLC
2013 - J. L. ALLEN CO., LLC
AROUND THE WEB
- Third Point, a Hedge Fund, Sets Its Activist Sights on Nestlé
By MICHAEL J. de la MERCED - Sunday Jun 25, 2017
- Shareholders Demand More Drastic Shifts at Nestlé
By STEPHANIE STROM - Tuesday Jun 27, 2017
The changes requested by the Third Point hedge fund underscore the idea that legacy food brands must radically shake up their portfolios to remain profitable.
- Subway Delays, Again, Disrupt Commutes; L.I.R.R. Will Offer Some Discounts
By EMMA G. FITZSIMMONS - Tuesday Jun 20, 2017
In what has become a seemingly weekly ritual, a series of problems cropped up across the city during the morning rush, including signal issues and a train with mechanical problems.
- Panelists bring issues of the country to the one percent
By Richard Morgan - Sunday Jul 16, 2017
It was the 1 percent who turned up at Allen & Co.’s media-and-tech conference in Sun Valley last week — but their agenda focused on issues for us common folk. Speakers acknowledged that America has turbulent race relations, a vulnerable economy and a military that’s no longer invincible. While none of this is new, Allen...
- Allen Iverson’s Philly homecoming got more awkward every minute
By Associated Press - Monday Jul 17, 2017
PHILADELPHIA — Allen Iverson walked onto a familiar court to a rousing ovation and then took an unfamiliar spot on the sideline. The Answer was Coach AI in his Big3 homecoming. Iverson said a few hours before his team played against Dr. J’s squad that his doctor advised him not to play Sunday night for...
- Blink Health Ends Pact With Express Scripts for Lilly Insulin Price Discounts
Tuesday Jun 13, 2017
Blink Health LLC, a provider of consumer price discounts for prescription drugs, said it has terminated its relationship with Express Scripts Holding Co., a pharmacy-benefit manager that helped arrange the new price break for Lilly’s insulin.